Point72 Hong Kong LTD Mersana Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$4.63 - $8.0 $70,172 - $121,248
15,156 New
15,156 $102,000
Q2 2022

Aug 15, 2022
SELL
$2.84 - $5.0 $40,555 - $71,400
-14,280 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$3.74 - $6.63 $19,100 - $33,859
5,107 Added 55.67%
14,280 $57,000
Q4 2021

Feb 14, 2022
BUY
$5.48 - $9.86 $50,268 - $90,445
9,173 New
9,173 $57,000
Q3 2021

Nov 15, 2021
SELL
$8.56 - $14.47 $75,781 - $128,102
-8,853 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$13.28 - $18.07 $80,702 - $109,811
6,077 Added 218.91%
8,853 $120,000
Q1 2021

May 17, 2021
BUY
$15.31 - $26.52 $42,500 - $73,619
2,776 New
2,776 $45,000
Q3 2020

Nov 16, 2020
SELL
$16.2 - $25.7 $96,341 - $152,837
-5,947 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$5.24 - $23.4 $31,162 - $139,159
5,947 New
5,947 $139,000
Q4 2019

Feb 14, 2020
SELL
$1.45 - $6.73 $1,473 - $6,837
-1,016 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$1.54 - $4.2 $1,564 - $4,267
1,016 New
1,016 $2,000
Q2 2019

Aug 14, 2019
SELL
$3.84 - $6.4 $2,718 - $4,531
-708 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$3.51 - $7.3 $2,485 - $5,168
708 New
708 $4,000
Q3 2018

Nov 14, 2018
SELL
$10.0 - $19.02 $6,830 - $12,990
-683 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$14.2 - $22.68 $9,698 - $15,490
683 New
683 $12,000

Others Institutions Holding MRSN

# of Institutions
125
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $59.3M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email